0001185185-17-002033.txt : 20170920
0001185185-17-002033.hdr.sgml : 20170920
20170920120712
ACCESSION NUMBER: 0001185185-17-002033
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170918
FILED AS OF DATE: 20170920
DATE AS OF CHANGE: 20170920
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: DODD DAVID A
CENTRAL INDEX KEY: 0001193607
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 002-93277-D
FILM NUMBER: 171093610
MAIL ADDRESS:
STREET 1: C/O SEROLOGICALS CORP
STREET 2: 5565 SPALDING DR
CITY: NORCROSS
STATE: GA
ZIP: 30092
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MEDIZONE INTERNATIONAL INC
CENTRAL INDEX KEY: 0000753772
STANDARD INDUSTRIAL CLASSIFICATION: WHOLESALE-DRUGS PROPRIETARIES & DRUGGISTS' SUNDRIES [5122]
IRS NUMBER: 870412648
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 350 EAST MICHIGAN AVENUE
STREET 2: SUITE 500
CITY: KALAMAZOO
STATE: MI
ZIP: 49007
BUSINESS PHONE: (269) 202-5020
MAIL ADDRESS:
STREET 1: 350 EAST MICHIGAN AVENUE
STREET 2: SUITE 500
CITY: KALAMAZOO
STATE: MI
ZIP: 49007
FORMER COMPANY:
FORMER CONFORMED NAME: MADISON FUNDING INC
DATE OF NAME CHANGE: 19860413
4
1
form4-dodd091917.xml
OWNERSHIP DOCUMENT
X0306
4
2017-09-18
0
0000753772
MEDIZONE INTERNATIONAL INC
MZEI
0001193607
DODD DAVID A
350 E. MICHIGAN AVE, STE 500
KALAMAZOO
MI
49007
1
1
0
0
Chief Executive Officer
Common stock
2017-09-18
4
A
0
1000000
0.00
A
1000000
D
Mr. Dodd received the stock upon appointment as Chief Executive Officer of the Company. The restricted stock will vest upon six months from the date of grant.
/s/ David A. Dodd
2017-09-20